2025³â 08¿ù 09ÀÏ Åä¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92622°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



Çö´ëÂ÷, Çë°¡¸® ¼ö¿äÀÀ´ä±³Åë ½Ã¹ü»ç¾÷ Âü¿©

¼ÅŬ Ç÷§Æû ±Û·Î¹ú »ç¾÷ È®Àå ±â¹Ý ¸¶·Ã
Çö´ëÂ÷°¡ Çë°¡¸®¿¡¼­ Áö¿ª ±³Åë ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇÑ ¼ö¿äÀÀ´ä±³Åë(Demand Responsive Transport, DRT) ¿î¿µ ½Ã¹ü»ç¾÷¿¡ Âü¿©ÇÑ´Ù. ±¹³» ¼º°øÀûÀÎ ¼ö¿äÀÀ´ä±³Åë ¼­ºñ½º Á¦°ø °æÇèÀ» ¹ÙÅÁÀ¸·Î ±Û·Î¹ú ½ÃÀåÀ¸·Î ¼­ºñ½º È®´ë¸¦ ÃßÁøÇÑ´Ù´Â Á¡¿¡¼­ Àǹ̰¡ ÀÖ´Ù. Çö´ëÀÚµ¿Â÷´Â Áö³­´Þ 31ÀÏ(ÇöÁö½Ã°¢) Çë°¡¸® ±«µÉ·Ú(Gödöllő)½Ã¿¡¼­ ¿­¸° ‘Çë°¡¸® ¼ö¿äÀÀ´ä±³Åë ¼­ºñ½º °³Åë½Ä’¿¡¼­ ÃÖ÷´Ü ¼ö¿äÀÀ´ä±³Åë Ç÷§ÆûÀ» Á¦°øÇϰí, ±Û·Î¹ú »ç¾÷ È®Àå ±â¹ÝÀ» ¸¶·ÃÇÑ´Ù°í 3ÀÏ(ÀÏ) ¹àÇû´Ù. °³Åë½Ä¿¡ µû¶ó 8¿ù 18ÀϺÎÅÍ 10¿ù ...

¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
Á¾Àãµ· 3õ¸¸ ¿øÀ¸·Î ºÎµ¿»ê ÅõÀÚ 1³â 2¹èÀÇ ¹ýÄ¢ (2016-06-23)
NILIT Announces Strategic Expansions, Including a Joint Vent... (2024-04-25)
¸¶Å©º£À̽º, ÀÌÂ÷ÀüÁö Å×½ºÆ® ÃÖÀûÈ­ ¼Ö·ç¼Ç ·ÐĪ (2024-02-07)
LIG³Ø½º¿ø, ÀÚȸ»çÇü Àå¾ÖÀÎÇ¥ÁØ»ç¾÷Àå ¡®ºí¶ûÁ¦¸®±æ¡¯ °³¼Ò (2024-06-04)
¡®Çؾ纸ȣ»ý¹° ¸Þ¸ð¸®°ÔÀÓ Ä÷¯¸µ¡¯ ESG üÇè ºÀ»ç ÁøÇà (2024-06-06)
[»ê¾÷] °¡»óÇö½ÇÀÇ ½ÃÀå Àúº¯ÀÌ È®´ëµÇ°í ÀÖ´Ù (2015-09-23)
Jetcraft Powers up With North American Broker Acquisition (2023-04-05)
KLPGA µÎ»ê°Ç¼³À§ºê èÇǾð½Ê, À̺¥Æ®È¦¼­ 2°³ÀÇ È¦Àοø (2024-04-10)
¼ö±¹ÀÇ ¼¶ µµÃʵµ 'È«¾î Àå¼ö ¹®¼øµæ ÃàÁ¦ 2024 ¹®Æä½ºÅ¸' (2024-06-27)
'ÇҰŸé ÁøÂ¥·Î' ÀνºÅ¸±×·¥ AR ÇÊÅÍ Ãâ½Ã ¹× À̺¥Æ® (2024-03-24)
ÀüÁֽà ¡®¼Ûõµ¿ ·Ôµ¥½Ã³×¸¶ ÆÄÀÎÆ®¸®¸ô¡¯ º¹ÇÕ »ó°¡ °Ç¸³ (2019-05-10)
´ëÇÑLPGÇùȸ ¡®LPG 1Åæ Æ®·° ¼­Æ÷ÅÍÁ 2±â ¸ðÁý (2024-08-08)
Kinaxis Teams Up with Non-Profit Leaders to Accelerate Socia... (2024-03-07)
³×¿ÀÇÇ¿¡½º ¡®³Ã°¨¼ÒÀç Æ¼¼ÅÃ÷¡¯ ³ì»öÀÎÁõ Ãëµæ (2023-10-24)
Çϸ², ´ß°¡½¿»ì ´Ü¹éÁú ÆÄ¿ì´õ üÇè´Ü ¸ðÁý (2024-01-29)
È¿¼ºÁß°ø¾÷, ¸ðÀáºñÅ©¿¡ ´ë±Ô¸ð Àü·Â±â±â °ø±Þ °è¾à (2024-06-14)
Bunjang Hosts a Successful Samsung Universe Pop-up to Commem... (2023-12-07)
Ãʰ³ÀÎÈ­ ÇコÄÉ¾î ¼­ºñ½º MOU (2023-10-11)
±Û¸°Æ®, ÆË¾÷½ºÅä¾î¡¤ÆÝµù µî Àαâ¸ôÀÌ¡¦ ȨÆäÀÌÁö ¿ÀÇ (2024-07-05)
Çö´ë¼º¿ì±×·ì, ´ëÇлý ¼­Æ÷ÅÍÁî ¡®Çö´ë¼º¿ì 縰Àú½º¡¯ 5±â ¸ðÁý (2024-06-18)
¡®¿ÀÇ ¸ÅÀå¿¡¼­ ¸¸³ª´Â Ưº°ÇÑ ÇýÅᯠ»ï¼º½ºÅä¾î ºÏ´ë±¸ °³Á¡ (2024-07-26)
Bureau Veritas Acquires Aligned Incentives, an Enterprise Su... (2024-10-29)
Global Progress Increasingly Uneven on the Road to a Connect... (2024-10-12)
¾Ö°æÄɹÌÄ®, SIB¿ë À½±Ø¼ÒÀç ¡®°í¼º´É ÇϵåÄ«º»¡¯ °³¹ß ¼º°ø (2024-05-15)
ÀüÇö¹«, ¸ÞÀο丮 ¡®Â¥±ÛÂ¥±Û ¹«±ÛÀÌ¡¯ ´ëÁ¢! ¡°Å»¸ð¿¡ ÁÁÀº À½... (2024-07-11)
       [ÀÌÀü][1]....[602][603][604][605][606][607][608][609][610]...[3705][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..